Intravenous Immuno Globulin IVIg Treatment Report

Category: Prescription Drugs

false

See also: Gammaglobulin (IVIg)

What is Intravenous Immuno Globulin IVIg?

An example of Intravenous Immuno Globulin IVIg

Intravenous Immune Globulin (IVIG) is a human blood product consisting of antibodies which is used to treat immunodeficiency disorders, B-cell chronic lymphocytic leukemia, inflammatory demyelinating disorders. Off label uses include Guillain-Barré, Multiple Sclerosis, and myasthenia gravis.

Reported Purpose & Perceived Effectiveness

Reasons and Perceived effectiveness
Perceived Effectiveness
Purpose # of patients # of patients with evaluations
Major
Moderate
Slight
None
Can’t tell
60 22 Efficacy_major Efficacy_moderate Efficacy_slight Efficacy_none Efficacy_cant_tell
14 1 Efficacy_major
13 4 Efficacy_major Efficacy_moderate Efficacy_slight
13 7 Efficacy_major Efficacy_moderate
11 3 Efficacy_slight Efficacy_none Efficacy_cant_tell
7 3 Efficacy_moderate Efficacy_cant_tell

See all 114 patients currently taking Intravenous Immuno Globulin IVIg

Mouse over the table for more information

Reported Dosages

Frequently reported dosages based on patients currently taking Intravenous Immuno Globulin IVIg. See all 74 dosages

  1 other monthly 5 g monthly 10 g monthly 10 g every other week 25 g monthly 30 mg monthly 30 g monthly 40 g monthly 60 g every other week 200 g monthly
  2 Number of Patients: 2 6 Number of Patients: 6 12 Number of Patients: 12 3 Number of Patients: 3 4 Number of Patients: 4 4 Number of Patients: 4 4 Number of Patients: 4 4 Number of Patients: 4 4 Number of Patients: 4 3 Number of Patients: 3  

Reported Stop Reasons

Why Patients Stopped Taking Intravenous Immuno Globulin IVIg (multiple reasons could be selected)
Reason # Patients Percentage of patients
Did not seem to work 48   Did not seem to work: 36%
Doctor's advice 39   Doctor's advice: 30%
Course of treatment ended 38   Course of treatment ended: 29%
Side effects too severe 20   Side effects too severe: 15%
Other 20   Other: 15%
Expense 7   Expense: 5%
Change in health plan coverage 5   Change in health plan coverage: 4%
Not indicated 4   Not indicated: 3%
Personal research 2   Personal research: 2%

See all 125 patients who’ve stopped taking Intravenous Immuno Globulin IVIg

Currently Taking Intravenous Immuno Globulin IVIg

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0

Stopped Taking Intravenous Immuno Globulin IVIg

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more

Reported Adherence, Burden & Cost See details from patient evaluations

Adherence

Taking treatment as prescribed

Adherence of Intravenous Immuno Globulin IVIg

Always
66 93%
Usually
1 1%
Sometimes
1 1%
Never
3 4%

Burden

Difficulty being on treatment

Burden of Intravenous Immuno Globulin IVIg

Very
5 7%
Somewhat
26 37%
A little
22 31%
Not at all
18 25%

Cost

Paid out of pocket

Cost of Intravenous Immuno Globulin IVIg

$200+
12 29%
$100-199
1 2%
$50-99
0 0%
$25-49
5 12%
< $25
23 56%

Sort by: Helpfulness | Most Recent

11 patient evaluations for Intravenous Immuno Globulin IVIg

Purpose: Multifocal Motor Neuropathy (Started Jun 11, 2012)
Date Dosage Perceived effectiveness Side Effects Adherence Burden
Jun 15, 2012 40 g Daily Led_efficacy_1Led_defaultLed_defaultLed_defaultNone MildMildMildMildMild AlwaysAlwaysAlwaysAlwaysAlways SomewhatSomewhatSomewhatSomewhatSomewhat
  • Icon_thumb_off 0 helpful marks
Purpose: ALS (Amyotrophic Lateral Sclerosis) (Started Aug 29, 2011)
Date Dosage Perceived effectiveness Side Effects Adherence Burden
Mar 30, 2012 40 g Weekly ?Can't tell NoneNoneNoneNoneNone AlwaysAlwaysAlwaysAlwaysAlways SomewhatSomewhatSomewhatSomewhatSomewhat
Date
Mar 30, 2012
Advice & Tips
didnt catch any colds over course stop is to evaluate effect severe side effects 1st week only
  • Icon_thumb_off 0 helpful marks
Purpose: Other (Started Apr 01, 2009)
Date Dosage Perceived effectiveness Side Effects Adherence Burden
Nov 15, 2010 1.5 g Monthly Led_efficacy_4Led_efficacy_4Led_efficacy_4Led_efficacy_4Major NoneNoneNoneNoneNone NeverNeverNeverNeverNever Not at allNot at allNot at allNot at allNot at all
Mar 05, 2010 1.5 g Monthly Led_efficacy_3Led_efficacy_3Led_efficacy_3Led_defaultModerate MildMildMildMildMild UsuallyUsuallyUsuallyUsuallyUsually SomewhatSomewhatSomewhatSomewhatSomewhat
Feb 04, 2010 1.5 g Monthly Led_efficacy_2Led_efficacy_2Led_defaultLed_defaultSlight ModerateModerateModerateModerateModerate AlwaysAlwaysAlwaysAlwaysAlways VeryVeryVeryVeryVery
Date
Mar 05, 2010
Advice & Tips
I think it helped
Cost
< $25 monthly
Date
Feb 04, 2010
Advice & Tips
one year once a mounth
Cost
< $25 monthly
  • Icon_thumb_off 0 helpful marks
1 2 3 4    You are at the first page First There is no previous page Prev | Next Go to the next page Last Go to the last page 

What is immune globulin intravenous?

Immune globulin intravenous is a sterilized solution made from human plasma. It contains the antibodies to help your body protect itself against infection from various diseases.

Immune globulin is used to treat primary immune deficiency, and to reduce the risk of infection in individuals with poorly functioning immune systems such as those with chronic lymphocytic leukemia (CLL). IGIV is also used to increase platelets (blood clotting cells) in people with idiopathic thrombocytopenic purpura (ITP) and to prevent aneurysm caused by a weakening of the main artery in the heart associated with Kawasaki syndrome.

Immune globulin is also used to treat chronic inflammatory demyelinating polyneuropathy (CIDP), a debilitating nerve disorder that causes muscle weakness and can affect daily activities.

Immune globulin may also be used for other purposes not listed in this medication guide.


Precautions

You should not use this medication if you have ever had an allergic reaction to an immune globulin or if you have immune globulin A (IgA) deficiency with antibody to IgA.

If you have certain conditions, you may need a dose adjustment or special tests to safely use this medication. Before you use immune globulin intravenous, tell your doctor if you have:

  • kidney disease;
  • diabetes (especially if you use insulin);
  • a history of stroke or blood clot;
  • heart disease or high blood pressure;
  • a condition called paraproteinemia; or
  • if you are over 65 years old.

FDA pregnancy category C. It is not known whether immune globulin is harmful to an unborn baby. Before using this medication, tell your doctor if you are pregnant or plan to become pregnant during treatment.

It is not known if immune globulin passes into breast milk or if it could harm a nursing baby. Do not use this medication without telling your doctor if you are breast-feeding a baby.

Do not receive live-virus vaccines such as measles, mumps, or rubella. The live vaccine may not work as well during this time, and may not fully protect you from disease.

Back to top

Instructions

Seek emergency medical attention if you think you have used too much of this medicine.

Call your doctor for instructions if you miss a dose of this medication.

Back to top

Side Effects

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.

Call your doctor at once if you have a serious side effect such as:

  • urinating less than usual or not at all, swelling, weight gain, feeling short of breath;
  • drowsiness, confusion, mood changes, increased thirst, loss of appetite, nausea and vomiting;
  • trouble breathing, blue lips;
  • fever with headache, neck stiffness, chills, increased sensitivity to light, purple spots on the skin, and/or seizure (convulsions);
  • pale or yellowed skin, dark colored urine, fever, confusion or weakness;
  • slow heart rate, weak pulse, fainting, slow breathing (breathing may stop);
  • sudden numbness or weakness, especially on one side of the body;
  • sudden headache, confusion, problems with vision, speech, or balance;
  • feeling like you might pass out;
  • fever, sore throat, and headache with a severe blistering, peeling, and red skin rash; or
  • nausea, stomach pain, low fever, loss of appetite, dark urine, clay-colored stools, jaundice (yellowing of the skin or eyes);

Less serious side effects may include:

  • headache;
  • dizziness;
  • upset stomach, mild nausea, vomiting, diarrhea;
  • back pain, joint pain, minor chest pain;
  • mild itching or skin rash; or
  • runny or stuffy nose, cough, sore throat;

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088. You may report side effects to FDA at 1-800-FDA-1088.

Back to top

Interactions

Immune globulin can be harmful to the kidneys, and these effects are increased when immune globulin is used together with other medicines that can harm the kidneys. Before taking immune globulin, tell your doctor if you are also using:

  • lithium (Lithobid);
  • methotrexate (Rheumatrex, Trexall);
  • pain or arthritis medicines such as aspirin (Anacin, Excedrin), acetaminophen (Tylenol), diclofenac (Cataflam, Voltaren), etodolac (Lodine), ibuprofen (Advil, Motrin), indomethacin (Indocin), naproxen (Aleve, Naprosyn), and others;
  • medicines used to treat ulcerative colitis, such as mesalamine (Pentasa) or sulfasalazine (Azulfidine);
  • medicines used to prevent organ transplant rejection, such as cyclosporine (Gengraf, Neoral, Sandimmune), sirolimus (Rapamune) or tacrolimus (Prograf);
  • IV antibiotics such as amphotericin B (Fungizone, AmBisome, Amphotec, Abelcet), amikacin (Amikin), bacitracin (Baci-IM), capreomycin (Capastat), gentamicin (Garamycin), kanamycin (Kantrex), streptomycin, or vancomycin (Vancocin, Vancoled);
  • antiviral medicines such as adefovir (Hepsera), cidofovir (Vistide), or foscarnet (Foscavir); or
  • cancer medicine such as aldesleukin (Proleukin), carmustine (BiCNU, Gliadel), cisplatin (Platinol), ifosfamide (Ifex), oxaliplatin (Eloxatin), plicamycin (Mithracin), streptozocin (Zanosar), or tretinoin (Vesanoid).

This list is not complete and there may be other drugs that can interact with immune globulin. Tell your doctor about all your prescription and over-the-counter medications, vitamins, minerals, herbal products, and drugs prescribed by other doctors. Do not start a new medication without telling your doctor.

Other Names

Carimune, Flebogamma, Gamimune N 5%, Gammagard, Gammagard S/D, Gammar-P I.V., Gamunex, Iveegam En, Octagam, Panglobulin, Polygam S/D, Sandoglobulin, Venoglobulin-S 10%, Venoglobulin-S 5%, immune globulin intravenous, Gamimune N 10%, Panglobulin NF, and Privigen

Back to top

Disclaimer

Every effort has been made to ensure that the information provided by Cerner Multum, Inc. ('Multum') is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Multum information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Multum does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Multum's drug information does not endorse drugs, diagnose patients or recommend therapy. Multum's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Multum does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 1996-2004 Cerner Multum, Inc. Version 2.05. Revision date 8/23/04

Last updated: